EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Effect of Glycyrrhizic Acid on Scopolamine-Induced Cognitive Impairment in Mice

Ju Yeon Ban, Hyun Kyung Park, Su Kang Kim

International Neurourology Journal · 31.05.2020 · 24 (Suppl 1) · S48-55

DOI: 10.5213/inj.2040154.077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Neurourology Journal, erschienen am 31.05.2020. Verfasst von Ju Yeon Ban und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dental Pharmacology, College of Dentistry, Dankook University, Cheonan, Korea. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Dankook University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Cognitive impairment is one of the main symptoms of Alzheimer disease and other dementias. Glycyrrhiza uralensis is a natural product that has a protective effect against cognitive impairment. In this study, we investigated whether glycyrrhizic acid, among the main bioactive components of Glycyrrhiza uralensis, has a neuroprotective effect on scopolamine-induced cognitive impairment.

Methods

Twenty-week-old male Institute of Cancer Research mice were used in this study. The scopolamine-induced cognitive impairment mice model was used. Glycyrrhizic acid was orally administered to mice once daily for 21 days, while scopolamine (1 mg/kg) treatment was delivered 30 minutes before behavioral tests. Donepezil (2 mg/kg) was used as a positive drug control. To evaluate the effect of glycyrrhizic acid, the following assessments were performed on hippocampal tissue: Y-maze test, acetylcholinesterase activity, antioxidant enzymes’ activity (superoxide dismutase, catalase). Western blotting for phosphor-extracellular signal-regulated kinase, P38, and c-Jun NH2-terminal kinase was conducted.

Results

We found that glycyrrhizic acid administration significantly improved scopolamine-induced cognitive impairment in the Y-maze test. The acetylcholinesterase activity, superoxide dismutase, and catalase activity in the glycyrrhizic acid-treated group showed a significant reversal of cognitive impairment compared with the scopolamine-treated group.

Conclusions

Our results suggest that glycyrrhizic acid has a neuroprotective effect on cognitive function in scopolamine-induced cognitive impairment.

Schlagwörter

Stichwörter der Autor:innen

Glycyrrhizic acidMemoryScopolamine

Autor:innen und Institutionen

  • Department of Dental Pharmacology, College of Dentistry, Dankook University, Cheonan, Korea.
  • Department of Emergency Medicine, Seoul Medical Center, Seoul, Korea.
  • Department of Biomedical Laboratory Science, Catholic Kwandong University, Gangneung, Korea.

Förderung

  • Dankook University

Zitieren

APA

Ban, J. Y., Park, H. K., & Kim, S. K. (2020). Effect of Glycyrrhizic Acid on Scopolamine-Induced Cognitive Impairment in Mice. International Neurourology Journal, 24(Suppl 1), S48-55. https://doi.org/10.5213/inj.2040154.077

Vancouver

Ban JY, Park HK, Kim SK. Effect of Glycyrrhizic Acid on Scopolamine-Induced Cognitive Impairment in Mice. International Neurourology Journal. 2020;24(Suppl 1):S48-55. doi:10.5213/inj.2040154.077

BibTeX
@article{Ban2020,
  author = {Ban, Ju Yeon and Park, Hyun Kyung and Kim, Su Kang},
  title = {Effect of Glycyrrhizic Acid on Scopolamine-Induced Cognitive Impairment in Mice},
  journal = {International Neurourology Journal},
  year = {2020},
  volume = {24},
  number = {Suppl 1},
  pages = {S48--55},
  doi = {10.5213/inj.2040154.077}
}
Kostenlos starten →